Treatment
Standard
of
Care
Figure 1. PARPi Use Opportunities in PARPi-Naïve Women with Stage
* Recommendations are color coded: Green indicates recommendations; yellow indicates
considerations for use. is figure should not be interpreted as justification for PARPi use
in >1 of these settings.
Disease
Life
Cycle
PARPi
Recommendations
CT ± bevacizumab
Bevacizumab
maintenance
Platinum
combination ±
bevacizumab
Bevacizumab
maintenance
Diagnosis End first-line
therapy
Platinum sensitive
recurrence
PARPi maintenance
PARPi treatment OR OR
May
be
used
Recommended
Chemotherapy ± bevacizumab ➞
PARPi + bev
